查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1743914

戒烟辅助市场－全球产业规模、份额、趋势、机会和预测（按产品、最终用户、地区和竞争细分，2020-2030 年）

Smoking Cessation Aids Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End-User, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球戒烟辅助市场价值为 230.2 亿美元，预计到 2030 年将以 7.28% 的复合年增长率强劲增长。该市场是医疗保健领域的重要组成部分，专注于透过一系列产品和服务帮助个人戒烟。随着人们对烟草使用相关健康风险的认识不断提高，戒烟辅助工具的采用率不断上升。市场包括尼古丁替代疗法 (NRT)、处方药、电子烟和数位介入。德国首款仿製尼古丁口香糖等创新解决方案的推出，以及 Achieve Life Sciences 的 ORCA-V1 研究等试验的良好临床结果，凸显了人们对可及有效戒烟辅助工具的日益重视。技术进步和消费者健康意识的增强正在推动个人化治疗方案的开发和应用，为未来几年市场稳步扩张奠定基础。

市场概览
预测期 2026-2030
2024年市场规模 230.2亿美元
2030年市场规模 348.1亿美元
2025-2030 年复合年增长率 7.28%
成长最快的领域 线上通路
最大的市场 北美洲

关键市场驱动因素

意识和健康问题日益增强

主要市场挑战

感知有效性和安全问题

主要市场趋势

数位戒烟解决方案的兴起

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球戒烟辅助市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（尼古丁替代疗法、药物、电子香烟等）
    • 按最终用户（医院药局、线上通路、零售药局、其他）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美戒烟辅助市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 美国
    • 加拿大
    • 墨西哥

第七章：欧洲戒烟辅助市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙

第八章：亚太地区戒烟辅助产品市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美洲戒烟辅助市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲戒烟辅助市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 最新动态
  • 产品发布
  • 併购

第 13 章：全球戒烟辅助市场：SWOT 分析

第 14 章：竞争格局

  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Novartis AG
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd
  • Takeda Pharmaceuticals Co. Ltd
  • British American Tobacco PLC
  • Kimree Technology Inc
  • Imperial Tobacco Ltd

第 15 章：策略建议

第16章调查会社について・免责事项

简介目录
Product Code: 16215

The Global Smoking Cessation Aids Market was valued at USD 23.02 billion in 2024 and is projected to witness robust growth at a CAGR of 7.28% through 2030. This market is a vital part of the healthcare landscape, focused on helping individuals quit smoking through a range of products and services. As awareness of the health risks associated with tobacco use increases, there is rising adoption of smoking cessation aids. The market includes nicotine replacement therapies (NRT), prescription medications, electronic cigarettes, and digital interventions. The introduction of innovative solutions, such as Germany's first generic nicotine chewing gum and promising clinical results from trials like Achieve Life Sciences' ORCA-V1 study, underscores the growing emphasis on accessible and effective quit-smoking aids. Technological advances and growing consumer health consciousness are driving the development and uptake of personalized treatment options, positioning the market for steady expansion in the coming years.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 23.02 Billion
Market Size 2030USD 34.81 Billion
CAGR 2025-20307.28%
Fastest Growing SegmentOnline Channels
Largest MarketNorth America

Key Market Drivers

Rising Awareness and Health Concerns

Increasing awareness of the health hazards linked to tobacco use is a major factor propelling the global smoking cessation aids market. Public understanding of the correlation between smoking and life-threatening diseases-such as cardiovascular disorders, respiratory illnesses, and cancers-has significantly grown, motivating individuals to seek out cessation support. Furthermore, the global emphasis on personal health and well-being is encouraging more people to take proactive steps toward quitting. As individuals prioritize longevity and a higher quality of life, demand for effective, science-backed smoking cessation products continues to rise. This heightened health consciousness is translating into increased usage of both over-the-counter and prescribed quit-smoking aids.

Key Market Challenges

Perceived Effectiveness and Safety Concerns

A notable challenge in the smoking cessation aids market is public skepticism surrounding the effectiveness and safety of available products. Some consumers doubt whether these aids genuinely improve quit rates or worry about potential side effects, particularly with pharmaceutical interventions. This hesitation can discourage individuals from using cessation aids altogether, opting instead for unsupported or self-guided attempts to quit. Addressing these concerns by reinforcing evidence-based outcomes and educating users on proper usage is critical for increasing adoption and trust in cessation therapies.

Key Market Trends

Rise in Digital Smoking Cessation Solutions

A growing trend in the smoking cessation landscape is the adoption of digital tools and services. Mobile apps, online coaching platforms, and telehealth services are becoming increasingly popular for their convenience, accessibility, and personalized features. These platforms offer real-time support, behavioral tracking, and adaptive quit plans that cater to individual needs. The integration of digital solutions reflects the broader shift in healthcare toward technology-driven interventions, opening new opportunities for engagement and treatment effectiveness in the smoking cessation market.

Key Market Players

  • Pfizer Inc.
  • GlaxoSmithKline PLC
  • Hoffmann-La Roche AG
  • Novartis AG
  • Johnson and Johnson
  • Bayer AG
  • Cipla Ltd
  • Takeda Pharmaceuticals Co. Ltd
  • British American Tobacco PLC
  • Kimree Technology Inc
  • Imperial Tobacco Ltd

Report Scope:

In this report, the Global Smoking Cessation Aids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Smoking Cessation Aids Market, By Product:

  • Nicotine Replacement Therapy
  • Drugs
  • Electronic Cigarettes
  • Others

Smoking Cessation Aids Market, By End-User:

  • Hospital Pharmacies
  • Online Channels
  • Retail Pharmacies
  • Other

Smoking Cessation Aids Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Smoking Cessation Aids Market.

Available Customizations:

Global Smoking Cessation Aids market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Smoking Cessation Aids Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Nicotine Replacement Therapy, Drugs, Electronic Cigarettes, Others)
    • 5.2.2. By End-User (Hospital Pharmacies, Online Channels, Retail Pharmacies, Other)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Smoking Cessation Aids Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-User
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Smoking Cessation Aids Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-User
    • 6.3.2. Canada Smoking Cessation Aids Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-User
    • 6.3.3. Mexico Smoking Cessation Aids Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-User

7. Europe Smoking Cessation Aids Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-User
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Smoking Cessation Aids Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-User
    • 7.3.2. United Kingdom Smoking Cessation Aids Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-User
    • 7.3.3. Italy Smoking Cessation Aids Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-User
    • 7.3.4. France Smoking Cessation Aids Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End-User
    • 7.3.5. Spain Smoking Cessation Aids Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End-User

8. Asia-Pacific Smoking Cessation Aids Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-User
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Smoking Cessation Aids Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-User
    • 8.3.2. India Smoking Cessation Aids Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-User
    • 8.3.3. Japan Smoking Cessation Aids Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-User
    • 8.3.4. South Korea Smoking Cessation Aids Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End-User
    • 8.3.5. Australia Smoking Cessation Aids Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End-User

9. South America Smoking Cessation Aids Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-User
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Smoking Cessation Aids Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-User
    • 9.3.2. Argentina Smoking Cessation Aids Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-User
    • 9.3.3. Colombia Smoking Cessation Aids Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-User

10. Middle East and Africa Smoking Cessation Aids Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End-User
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Smoking Cessation Aids Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End-User
    • 10.3.2. Saudi Arabia Smoking Cessation Aids Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End-User
    • 10.3.3. UAE Smoking Cessation Aids Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Product Launches
  • 12.3. Mergers & Acquisitions

13. Global Smoking Cessation Aids Market: SWOT Analysis

14. Competitive Landscape

  • 14.1. Pfizer Inc.
    • 14.1.1. Business Overview
    • 14.1.2. End-User Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Key Personnel
    • 14.1.5. SWOT Analysis
  • 14.2. GlaxoSmithKline PLC
  • 14.3. Hoffmann-La Roche AG
  • 14.4. Novartis AG
  • 14.5. Johnson and Johnson
  • 14.6. Bayer AG
  • 14.7. Cipla Ltd
  • 14.8. Takeda Pharmaceuticals Co. Ltd
  • 14.9. British American Tobacco PLC
  • 14.10. Kimree Technology Inc
  • 14.11. Imperial Tobacco Ltd

15. Strategic Recommendations

16. About Us & Disclaimer